Gong Jiuyu, Tian Fangfang, Wang Qin, Mu Mi, Geng Sijia, Hao Pengfei, Zhong Pengfei, Zhang Rui, Jiang Lin, Wang Rentao, Bao Pengtao
Hubei Province Corps Hospital of CAPF, Wuhan, China.
The Eighth Medical Center of Chinese PLA General Hospital, College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.
Front Med (Lausanne). 2022 Dec 15;9:1066870. doi: 10.3389/fmed.2022.1066870. eCollection 2022.
Pulmonary epithelioid hemangioendothelioma (PEH) is a rare vascular tumor of endothelial origin with low- to intermediate-grade malignant potentials. Since there is no characteristic clinical or biological marker available for PEH, most cases require a surgical lung biopsy for diagnosis. To date, although some patients with PEH reported in the literature were diagnosed through bronchoscopic biopsy, most of the patients still underwent surgical lung biopsy for confirmation. In this case report, we present a rare case diagnosed as PEH through endobronchial biopsies due to the presence of an intraluminal mass that blocked the trachea and caused atelectasis in the right upper lobe. Moreover, since surgery was not appropriate for this patient with unresectable bilateral multiple nodules, we adopted genetic analysis using NGS to provide a guide for personalized treatment. Then, based on the NGS results, the patient was treated with anti-PD-1 mAb and sirolimus for 1 year and has been stable in a 1-year follow-up examination.
肺上皮样血管内皮瘤(PEH)是一种罕见的起源于内皮的血管肿瘤,具有低至中度恶性潜能。由于目前尚无针对PEH的特征性临床或生物学标志物,大多数病例需要进行手术肺活检以明确诊断。迄今为止,尽管文献报道的一些PEH患者是通过支气管镜活检确诊的,但大多数患者仍需接受手术肺活检以进行确诊。在本病例报告中,我们介绍了一例罕见病例,该病例因腔内肿物阻塞气管并导致右上叶肺不张,通过支气管内活检确诊为PEH。此外,由于该患者双侧多发结节无法切除,手术并不适宜,因此我们采用二代测序(NGS)进行基因分析,为个性化治疗提供指导。然后,根据NGS结果,该患者接受抗程序性死亡受体1(PD-1)单克隆抗体和西罗莫司治疗1年,在1年的随访检查中病情一直稳定。